| Name | Title | Contact Details |
|---|---|---|
Clare Hunt |
Chief People Officer | Profile |
New York Med And Diagnstc Center is a Kew Gardens, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Home Instead Senior Care® network is the world`s leading provider of personalized in-home care services. We have over 1,100 independently owned and operated franchise offices worldwide that employ compassionate CAREGivers who share our dedication to enhancing the lives of aging adults and their families. Services span the care continuum, from companionship and personal care to specialized Alzheimer`s care and hospice support. Caring for others is part of our DNA, and that includes caring for your career. The Home Instead Senior Care network provides best-in-class training, education, and opportunities for career advancement. It also offers you the opportunity to be part of a supportive family-like culture where you`re encouraged to talk with your local office for support, share stories, and seek guidance.
Mid-Atlantic Dental Partners delivers dental services through a partnership with dentists who are respected in their communities.
Windham Community Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Windham Community Memorial Hospital is based in Willimantic, CT. You can find more information on Windham Community Memorial Hospital at www.wcmh.org
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.